Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2008 Jun;31(3):198-207.
doi: 10.1007/s10753-008-9065-3. Epub 2008 Mar 18.

C-reactive protein is linked to lower cognitive performance in overweight and obese women

V Sweat  1 , V Starr, H Bruehl, A Arentoft, A Tirsi, E Javier, A Convit
Affiliations
Comparative Study

C-reactive protein is linked to lower cognitive performance in overweight and obese women

V Sweat et al. Inflammation. 2008 Jun.

Abstract

Our objective was to ascertain the nature of the associations between C-reactive protein (CRP) and cognition, and to examine how they are affected by gender and obesity. We evaluated 62 females and 63 males between 42 and 82 years of age. There were 20 lean females with a body mass index (BMI) of <25 kg/m2 and 42 overweight or obese females, with BMIs > or =25 kg/m2. There were 14 lean males and 49 with BMIs >/=25 kg/m2. CRP was associated with lower scores on cognitive tests of frontal lobe function among females and these associations were driven by the overweight/obese female group. In these data no associations between CRP and cognition were found among males. Obesity-associated inflammation is much more prominent in females and it appears to be associated with cognitive dysfunction, particularly of frontal lobe tasks.

PubMed Disclaimer

References

    1. Lee W-Y, Park J-S, Noh S-Y, Rhee E-J, Sung K-C, Kim B-S, Kang J-H, Kim S-W, Lee M-H, Park J-R. C-reactive protein concentrations are related to insulin resistance and metabolic syndrome as defined by the ATP III report. International Journal of Cardiology. 2004;97:101–6. - PubMed
    1. Wang Z, Hoy WE. C-reactive protein and the risk of developing type 2 diabetes in Aboriginal Australians. Diabetes Research And Clinical Practice. 2007;76:37–43. - PubMed
    1. Han T, Gonzalez-Villalpando C, Sattar N, Lean M, Williams K, Haffner SM. Prospective Study of C-Reactive protein in Relation to the Development of Diabetes and Metabolic Syndrome in the Mexico City Diabetes Study. Diabetes Care. 2007;25(11):2016–21. - PubMed
    1. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, III, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC, Jr., Taubert K, Tracy RP, Vinicor F. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003 Jan;107(3):499–511. - PubMed
    1. Kushner I, Rzewnicki D, Samols D. What Does Minor Elevation of C-Reactive Protein Signify? American Journal of Medicine. 2006;119:166.e17–166.e28. - PubMed

Publication types

MeSH terms